Cite
MLA Citation
Ying Yang et al.. “REBACIN® is an optional intervention for persistent high‐risk human papillomavirus infection: A retrospective analysis of 364 patients.” International journal of gynaecology and obstetrics, vol. 152, no. 1, 2021, pp. 82–87. http://access.bl.uk/ark:/81055/vdc_100117925917.0x000058